Rats were given glycyl-L-glutamine (Gly-Gin) by intraaortic infusion with Alzet osmotic pumps during the 48-hr period following the intraaortic administration of diisopropyl phosphorofluoridate (DFP) (10 ,umol/kg). The infusion of 1.2 ,umol of Gly-Gln per 24 hr resulted in a significant increase in the acetyicholinesterase (AcChoEase; acetylcholine acetylhydrolase, EC 3.1.1.7) activity of the gastrocnemius muscles over that of rats that received DFP only. At a total dose of 3.6 ,umol per 24 hr, a diminished result was obtained; at 0.36 jimol per 24 hr, no effect was detectable. These findings, together with earlier ones, suggest that the neurotrophic effect of Gly-Gln or a similar endogenous factor on AcChoEase synthesis is a general phenomenon at sites of cholinergic transmission.
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In a series of experiments performed over the past few years (summarized in ref. 1) , it was shown that the intraarterial infusion of either an unidentified small endogenous peptide or glycyl-L-glutamine (Gly-Gln) opposes the fall in acetylcholinesterase (AcChoEase; acetylcholine acetylhydrolase, EC 3.1.1.7) and butyrylcholine esterase (BtChoEase; cholinesterase; acylcholine acylhydrolase, EC 3.1.1.8) that otherwise follows preganglionic denervation of the cat superior cervical ganglion (SCG). Both the endogenous and synthetic peptides were shown to act at a stage prior to the aggregation of the monomeric (G1) form of AcChoEase into the tetrameric (G4) globular and asymmetric (A12) forms (2) . It was proposed that they might act by regulating the transcription of the DNAs for AcChoEase and BtChoEase to the corresponding mRNAs (1, 3) in a manner analogous to that proposed for triiodothyronine (4) .
The present experiments were undertaken to determine whether this action of Gly-Gln occurs at sites of cholinergic transmission other than the SCG of the cat. Evidence is presented that it occurs also in skeletal muscle of the rat. Here it appears to be a rate-limiting factor in the regeneration of AcChoEase following its inactivation by diisopropyl phosphorofluoridate (DFP).
METHODS
In brief, rats were injected via the abdominal aorta with a dose of DFP that produced >90% inactivation of the AcChoEase of the gastrocnemius muscles. Experimental animals were then given continuous infusions of Gly-Gln into the abdominal aorta by means of Alzet osmotic pumps. Two days later, the rats were sacrificed and the gastrocnemius muscles were excised, extracted, and assayed for AcChoEase and protein contents.
DFP was prepared as a 0.1 M stock solution in anhydrous propylene glycol and was stored in a refrigerated (50C) desiccator for a maximum of 2 weeks; past experience has shown that little activity is lost under these conditions. It was diluted to 0.01 M in 0.9% NaCl solution within 1 hr ofthe time of administration. However, to minimize the effects of DFP deterioration and other variables on results, all experiments were conducted with matched pairs of rats-i.e., a control (DFP only) and experimental (DFP plus Gly-Gln) animal run on the same day or within 1 day of each other; all quantitative comparisons were made with groups of such pairs.
Rats were anesthetized with sodium pentobarbital (-40 mg/kg, i.p.) and were given atropine (10 mg/kg, i.p.). The left renal artery was exposed and a PE 10 intramedic polyethylene catheter (o.d., 0.61 mm) was inserted into the central end to the level of the abdominal aorta. The catheter was ligated in place, and DFP (1.0 ml; 0.01 mol/kg) was injected. In control rats, the catheter was then flame-sealed and the abdominal muscles and skin were sutured; Combiotic (penicillin plus dihydrostreptomycin) (0.3 ml) was injected i.m. In experimental rats after DFP, the catheter was rinsed with 0.4 ml of the same concentration of Gly-Gln as was present in the osmotic pump, and the pump was attached to the catheter and implanted loosely and sutured within the peritoneal cavity.
Forty-eight hours after the injection of DFP, rats were sacrificed by decapitation and both gastrocnemii were excised, trimmed of adherent nerves and tendons, scissorminced, and homogenized in AcChoEase extraction medium (1 M NaCl/1% Triton X-100/0.05 M MgC12/0.02 M Tris HCl, pH 7.4) at 9.0 ml per g (wet weight) of muscle. Homogenization was done at full speed for 1 min in a Janke & Kunkel Kika-Werk Ultra-Turrax (Tekmar, Cincinnati) with an icewater bath, homogenates were centrifuged at full speed for 30 min in a Dynac centrifuge (Clay Adams), and the clear supernate was collected. AcChoEase was assayed by a modification (5) ofthe method of Ellman et al. (6) , and protein was assayed by the Lowry et al. (7) method.
The initial concentration of Gly-Gln for filling the osmotic pumps (Alzet Model 2001; nominal pumping rate, 1 ,ul/hr; duration, 1 week; capacity, 200 ,ul) was chosen as follows. It was found in cats that the maximal effect for preservation of the AcChoEase of the denervated SCG was obtained with the intracarotid infusion of -400 ml of 3 ,uM Gly-Gln plus heat-treated plasma over 24 hr, or a total dose of 1.2 ,mol. At three times this concentration, the effect was minimal, and at still higher concentrations it was distinctly inhibitory. The effect was markedly reduced with the infusion of 1 ,uM Gly-Gln or with lower concentrations (8) . On the assumption that the mass of the hind quarters of the rats used (400-600 g) was approximately the same as that of the head of the cat, Abbreviations: AcChoEase, acetylcholinesterase; DFP, diisopropyl phosphorofluoridate; Gly-Gln, glycyl-L-glutamine; SCG, superior cervical ganglion (ganglia).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. the pumps were filled with 0.05 M Gly-Gln dissolved in 75% heat-inactivated (60'C for 60 min) cat plasma, for the delivery of 1.2 umol per 24 hr. Following the demonstration of a significant positive effect under these conditions in a series of five control and five experimental rats (see Results), smaller series were run with concentrations of 0.015 and 0.15 M Gly-Gln.
RESULTS
Control values, obtained with the gastrocnemii offive normal rats and of three rats sacrificed 100-110 min after the intraaortic injection of 1.0 ml of 0.01 M DFP per kg are shown in Table 1 . This dose of DFP reduced the mean AcChoEase activity of the muscles to "'8% of the control value.
In the five DFP-injected rats (U-B) matched with five rats also given infusions of 0.05 M Gly-Gln (T-C) shown in Table  2 At a 3-fold higher dose (0.15 M), the mean value of the experimental (H, M, Q) group is approximately twice that of the control (K, L, P, R) group. However, the difference is not statistically significant. The initial latency in the synthesis of AcChoEase [i.e., 7.6% of controls at 100 min post-DFP (Table 1) , and 14.7-21.8% at 48 hr post-DFP (Table 2) ] is consistent with results obtained several years ago with rat gastrocnemii after the intramuscular injection of DFP (9) . In the present study, the mean value for the gastrocnemii of two rats sacrificed 5 days after DFP was 57.2% ±+-11.1%, which is also in the same range as the corresponding value from the earlier study.
It is probably fortuitous that the same total intraarterial dose of Gly-Gln (i.e., 1.2 ttmol per 24 hr) that was maximally effective in opposing the fall in AcChoEase in the denervated SCG of the cat (8) was also near-optimal for enhancing the rate of synthesis of AcChoEase in the rat gastrocnemius muscle following its inactivation by DFP. As with the cat SCG, it appears that at doses sufficiently above the optimal, a decreased result is obtained (see means with 0.05 and 0.15 M Gly-Gln in Table 2 ); however, an insufficient number of animals was used to make this difference statistically significant.
The present results suggest that the neurotrophic effect of Gly-Gln on AcChoEase synthesis is probably a general one at sites of cholinergic transmission.
